Shah R, Wang R
Nat Metab. 2025; .
PMID: 40045117
DOI: 10.1038/s42255-025-01241-w.
Yordanov A, Damyanova P, Vasileva-Slaveva M, Hasan I, Kostov S, Shivarov V
Int J Mol Sci. 2024; 25(16).
PMID: 39201801
PMC: 11354974.
DOI: 10.3390/ijms25169117.
Cazzato G, Ingravallo G, Ribatti D
Cancers (Basel). 2024; 16(10).
PMID: 38791873
PMC: 11120419.
DOI: 10.3390/cancers16101794.
Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kolat D
J Hematol Oncol. 2024; 17(1):33.
PMID: 38745196
PMC: 11094969.
DOI: 10.1186/s13045-024-01541-w.
Hu Y, Sarkar A, Song K, Michael S, Hook M, Wang R
Cell Rep Med. 2024; 5(5):101530.
PMID: 38688275
PMC: 11148642.
DOI: 10.1016/j.xcrm.2024.101530.
Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis.
Gewalt T, Diehl L, Meder L
Front Oncol. 2024; 14:1373308.
PMID: 38444685
PMC: 10914249.
DOI: 10.3389/fonc.2024.1373308.
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G
Front Immunol. 2024; 14:1325360.
PMID: 38292487
PMC: 10824957.
DOI: 10.3389/fimmu.2023.1325360.
Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
Zhang H, Yang Y, Xing W, Li Y, Zhang S
BMC Cancer. 2023; 23(1):1124.
PMID: 37978469
PMC: 10656989.
DOI: 10.1186/s12885-023-11574-y.
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis S, Savioli F, Ammar A, Al-Badran S, Hatthakarnkul P, Leslie H
Histol Histopathol. 2023; 39(2):177-200.
PMID: 37681672
DOI: 10.14670/HH-18-655.
: Pathogenesis and therapeutic targets.
Yang J, Zhang L, Qiao W, Luo Y
MedComm (2020). 2023; 4(5):e353.
PMID: 37674971
PMC: 10477518.
DOI: 10.1002/mco2.353.
Asparagine restriction enhances CD8 T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response.
Gnanaprakasam J, Kushwaha B, Liu L, Chen X, Kang S, Wang T
Nat Metab. 2023; 5(8):1423-1439.
PMID: 37550596
PMC: 10447245.
DOI: 10.1038/s42255-023-00856-1.
Uncoding the interdependency of tumor microenvironment and macrophage polarization: insights from a continuous network approach.
de Leon U, Vazquez-Jimenez A, Padilla-Longoria P, Resendis-Antonio O
Front Immunol. 2023; 14:1150890.
PMID: 37283734
PMC: 10240616.
DOI: 10.3389/fimmu.2023.1150890.
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Evans J, Suman S, Goruganthu M, Tchekneva E, Guan S, Arasada R
J Natl Cancer Inst. 2023; 115(11):1404-1419.
PMID: 37195421
PMC: 10637048.
DOI: 10.1093/jnci/djad091.
Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells.
Ghanbari-Movahed M, Shafiee S, Burcher J, Lagoa R, Farzaei M, Bishayee A
Metabolites. 2023; 13(3).
PMID: 36984844
PMC: 10051376.
DOI: 10.3390/metabo13030404.
HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
Missiaen R, Lesner N, Simon M
EMBO J. 2023; 42(6):e112067.
PMID: 36808622
PMC: 10015374.
DOI: 10.15252/embj.2022112067.
Prognostic Utility of CD47 in Cancer of the Uterine Cervix and the Sensitivity of Immunohistochemical Scores.
Yordanov A, Shivarov V, Kostov S, Ivanova Y, Dimitrova P, Popovska S
Diagnostics (Basel). 2023; 13(1).
PMID: 36611344
PMC: 9818840.
DOI: 10.3390/diagnostics13010052.
Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review.
Kobayashi H
Heliyon. 2022; 8(11):e11487.
PMID: 36406733
PMC: 9668530.
DOI: 10.1016/j.heliyon.2022.e11487.
Non-coding RNA-mediated high expression of as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer.
Chen K, Gong S, Fang X, Li Q, Ye M, Li J
Front Immunol. 2022; 13:920136.
PMID: 36159813
PMC: 9493355.
DOI: 10.3389/fimmu.2022.920136.
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells.
Chowdhury S, Kar A, Bhowmik D, Gautam A, Basak D, Sarkar I
Cancer Res. 2022; 82(14):2640-2655.
PMID: 35648389
PMC: 7613107.
DOI: 10.1158/0008-5472.CAN-21-4052.
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.
van Genugten E, Weijers J, Heskamp S, Kneilling M, van den Heuvel M, Piet B
Front Oncol. 2022; 11:786089.
PMID: 35070990
PMC: 8779734.
DOI: 10.3389/fonc.2021.786089.